A PYMNTS Company

EU: In-depth probe opened into Zimmer, Biomet merger

By  |  October 5, 2014

US medical device company Zimmer is facing an in-depth probe by competition authorities in Europe over its proposed buyout of Biomet for $13.4 billion, reports say.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The European Commission said Friday it opened a formal investigation of the transaction to pressure Zimmer into offering concessions to secure regulatory clearance for the buyout. Reports say following the takeover, Zimmer will become the world’s second-largest seller of orthopedic products behind Johnson & Johnson.

    The Commission will reportedly rule on the deal by February 16 of next year.

    Full content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.